Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsReceivables - NetShares Repurchased
Ratios

Tg Therapeutics (TGTX) Long-Term Debt Issuances (2019 - 2024)

Tg Therapeutics (TGTX) has 3 years of Long-Term Debt Issuances data on record, last reported at $244.8 million in Q3 2024.

  • For Q3 2024, Long-Term Debt Issuances changed N/A year-over-year to $244.8 million; the TTM value through Dec 2025 reached $244.8 million, changed 0.0%, while the annual FY2024 figure was $244.8 million, 879.26% up from the prior year.
  • Long-Term Debt Issuances reached $244.8 million in Q3 2024 per TGTX's latest filing, up from $25.0 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $244.8 million in Q3 2024 and bottomed at $25.0 million in Q1 2023.